Influenza vaccination increases anti-JC virus antibody levels during treatment with Natalizumab: Case report
详细信息 查看全文
- 作者：Jahir Andres Miranda Acuñ ; aa ; jahirmiranda@yahoo.com.co" class="auth_mail" title="E-mail the corresponding author ; Bianca Weinstock-Guttmanb ; c ; d ; e
- 关键词：Natalizumab ; JC virus ; Progressive multifocal leukoencephalopathy ; Influenza vaccination
- 刊名：Multiple Sclerosis and Related Disorders
- 出版年：2016
- 出版时间：September 2016
- 年：2016
- 卷：9
- 期：Complete
- 页码：54-55
- 全文大小：320 K
文摘
- •
Natalizumab (NTZ) is one of the most effective therapies for MS.
- •
Common concern with NTZ is the risk of progressive multifocal leukoencephalopathy.
- •
Influenza vaccination converted to a high positive anti-JCV index in a MS patient.
- •
Vaccination could be a factor that can affect JCV index.